CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

Name: CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
License: Public Domain

Mahmoud Ramadan mohamed Elkazzaz

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid-19 respiratory infection

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127613
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.